These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3927511)

  • 21. Macrophage migration in fibrin gel matrices. II. Effects of clotting factor XIII, fibronectin, and glycosaminoglycan content on cell migration.
    Lanir N; Ciano PS; Van de Water L; McDonagh J; Dvorak AM; Dvorak HF
    J Immunol; 1988 Apr; 140(7):2340-9. PubMed ID: 3351302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of fibronectin fragments on macrophage phagocytosis of gelatinized particles.
    Rourke FJ; Blumenstock FA; Kaplan JE
    J Immunol; 1984 Apr; 132(4):1931-6. PubMed ID: 6230398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombin interaction with a recombinant N-terminal extracellular domain of the thrombin receptor in an acellular system.
    Bouton MC; Jandrot-Perrus M; Moog S; Cazenave JP; Guillin MC; Lanza F
    Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):635-41. PubMed ID: 7832783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of the modulation of the fibronectin-binding capacity of fibrin by thrombin on osteoblast differentiation.
    Oh JH; Kim HJ; Kim TI; Baek JH; Ryoo HM; Woo KM
    Biomaterials; 2012 Jun; 33(16):4089-99. PubMed ID: 22386921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-linking of alpha 2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor.
    Tamaki T; Aoki N
    Biochim Biophys Acta; 1981 Oct; 661(2):280-6. PubMed ID: 7295739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of fibronectin fragments that bind to carboxy-group-modified proteins.
    Vuento M; Sekiguchi K; Korkolainen M
    Biochem J; 1983 Dec; 215(3):613-6. PubMed ID: 6661187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probing the distance between the two binding sites of hirudin for its interaction with the active site and the fibrin(ogen)-binding site of alpha-thrombin.
    Wagner U; Schmitz T; Otte M; Dodt J
    Biomed Biochim Acta; 1991; 50(4-6):707-10. PubMed ID: 1801747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a mode of specific binding of fibrin monomer through its amino-terminal domain by macrophages and macrophage cell-lines.
    Shainoff JR; Stearns DJ; DiBello PM; Hishikawa-Itoh Y
    Thromb Haemost; 1990 Apr; 63(2):193-203. PubMed ID: 2163552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localization of the binding site on fibrin for the secondary binding site of thrombin.
    Vali Z; Scheraga HA
    Biochemistry; 1988 Mar; 27(6):1956-63. PubMed ID: 3378041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basis for the reduced affinity of beta T- and gamma T-thrombin for hirudin.
    Stone SR; Hofsteenge J
    Biochemistry; 1991 Apr; 30(16):3950-5. PubMed ID: 2018764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of substrate specificity for factor XIII.
    McDonagh J; Fukue H
    Semin Thromb Hemost; 1996; 22(5):369-76. PubMed ID: 8989819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of two fibrin-binding domains in plasma fibronectin and unequal distribution of these domains in two different subunits: a preliminary note.
    Sekiguchi K; Hakomori S
    Biochem Biophys Res Commun; 1980 Nov; 97(2):709-15. PubMed ID: 7470122
    [No Abstract]   [Full Text] [Related]  

  • 34. Human keratinocytes adhere to two distinct heparin-binding synthetic peptides derived from fibronectin.
    Wilke MS; Skubitz AP; Furcht LT; McCarthy JB
    J Invest Dermatol; 1991 Sep; 97(3):573-9. PubMed ID: 1875056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional properties of a recombinant chimeric protein with combined thrombin inhibitory and plasminogen-activating potential.
    Lijnen HR; Wnendt S; Schneider J; Janocha E; Van Hoef B; Collen D; Steffens GJ
    Eur J Biochem; 1995 Nov; 234(1):350-7. PubMed ID: 8529664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity relationships of recombinant hirudins.
    Stürzebecher J; Walsmann P
    Semin Thromb Hemost; 1991 Apr; 17(2):94-8. PubMed ID: 1771418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibited thrombins. Interactions with fibrinogen and fibrin.
    Kaminski M; McDonagh J
    Biochem J; 1987 Mar; 242(3):881-7. PubMed ID: 3593282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding and internalization of soluble fibrin by thrombocytes.
    Hörmann H; Richter H; Jelinić V
    Thromb Res; 1990 Apr; 58(2):175-83. PubMed ID: 2349544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.
    Sakata Y; Aoki N
    J Clin Invest; 1980 Feb; 65(2):290-7. PubMed ID: 6444305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Domain structure of human plasma and cellular fibronectin. Use of a monoclonal antibody and heparin affinity to identify three different subunit chains.
    Click EM; Balian G
    Biochemistry; 1985 Nov; 24(23):6685-96. PubMed ID: 2417623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.